 | • レポートコード：QY2203B11923 • 出版社/出版日：QYResearch / 2022年3月25日 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の大うつ病治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に大うつ病治療薬の世界市場のxxx％を占める「アリピプラゾール」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の大うつ病治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの大うつ病治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの大うつ病治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 大うつ病治療薬のグローバル主要メーカーには、Bristol-Myers Squibb Company、Cerecor Inc.、e-Therapeutics Plc、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、H. Lundbeck A/S、Hua Medicine Ltd.、Intra-Cellular Therapies, Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 大うつ病治療薬市場は、種類と用途によって区分されます。世界の大うつ病治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 アリピプラゾール、AV-101、AVP-786、バシムグラント、ブレクスピプラゾール、その他 【用途別セグメント】 病院、診療所、研究所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 大うつ病治療薬製品概要 - 種類別市場（アリピプラゾール、AV-101、AVP-786、バシムグラント、ブレクスピプラゾール、その他） - 用途別市場（病院、診療所、研究所） - 調査の目的 ・エグゼクティブサマリー - 世界の大うつ病治療薬販売量予測2017-2028 - 世界の大うつ病治療薬売上予測2017-2028 - 大うつ病治療薬の地域別販売量 - 大うつ病治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別大うつ病治療薬販売量 - 主要メーカー別大うつ病治療薬売上 - 主要メーカー別大うつ病治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（アリピプラゾール、AV-101、AVP-786、バシムグラント、ブレクスピプラゾール、その他） - 大うつ病治療薬の種類別販売量 - 大うつ病治療薬の種類別売上 - 大うつ病治療薬の種類別価格 ・用途別市場規模（病院、診療所、研究所） - 大うつ病治療薬の用途別販売量 - 大うつ病治療薬の用途別売上 - 大うつ病治療薬の用途別価格 ・北米市場 - 北米の大うつ病治療薬市場規模（種類別、用途別） - 主要国別の大うつ病治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの大うつ病治療薬市場規模（種類別、用途別） - 主要国別の大うつ病治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の大うつ病治療薬市場規模（種類別、用途別） - 主要国別の大うつ病治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の大うつ病治療薬市場規模（種類別、用途別） - 主要国別の大うつ病治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの大うつ病治療薬市場規模（種類別、用途別） - 主要国別の大うつ病治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Bristol-Myers Squibb Company、Cerecor Inc.、e-Therapeutics Plc、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、H. Lundbeck A/S、Hua Medicine Ltd.、Intra-Cellular Therapies, Inc. ・産業チェーン及び販売チャネル分析 - 大うつ病治療薬の産業チェーン分析 - 大うつ病治療薬の原材料 - 大うつ病治療薬の生産プロセス - 大うつ病治療薬の販売及びマーケティング - 大うつ病治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 大うつ病治療薬の産業動向 - 大うつ病治療薬のマーケットドライバー - 大うつ病治療薬の課題 - 大うつ病治療薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Major Depressive Disorder Drug Market
Due to the COVID-19 pandemic, the global Major Depressive Disorder Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Aripiprazole accounting for % of the Major Depressive Disorder Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Major Depressive Disorder Drug market size is valued at US$ million in 2021, while the US and Europe Major Depressive Disorder Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Major Depressive Disorder Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Major Depressive Disorder Drug include Bristol-Myers Squibb Company, Cerecor Inc., e-Therapeutics Plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, H. Lundbeck A/S, Hua Medicine Ltd. and Intra-Cellular Therapies, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Major Depressive Disorder Drug Scope and Segment
Major Depressive Disorder Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Aripiprazole
AV-101
AVP-786
Basimglurant
Brexpiprazole
Others
Segment by Application
Hospital
Clinic
Research Center
By Company
Bristol-Myers Squibb Company
Cerecor Inc.
e-Therapeutics Plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
H. Lundbeck A/S
Hua Medicine Ltd.
Intra-Cellular Therapies, Inc.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Major Depressive Disorder Drug Product Introduction
1.2 Market by Type
1.2.1 Global Major Depressive Disorder Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aripiprazole
1.2.3 AV-101
1.2.4 AVP-786
1.2.5 Basimglurant
1.2.6 Brexpiprazole
1.2.7 Others
1.3 Market by Application
1.3.1 Global Major Depressive Disorder Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Major Depressive Disorder Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Major Depressive Disorder Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Major Depressive Disorder Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Major Depressive Disorder Drug Sales by Region
2.4.1 Global Major Depressive Disorder Drug Sales by Region (2017-2022)
2.4.2 Global Sales Major Depressive Disorder Drug by Region (2023-2028)
2.5 Global Major Depressive Disorder Drug Revenue by Region
2.5.1 Global Major Depressive Disorder Drug Revenue by Region (2017-2022)
2.5.2 Global Major Depressive Disorder Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Major Depressive Disorder Drug Sales by Manufacturers
3.1.1 Global Top Major Depressive Disorder Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Major Depressive Disorder Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Major Depressive Disorder Drug in 2021
3.2 Global Major Depressive Disorder Drug Revenue by Manufacturers
3.2.1 Global Major Depressive Disorder Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Major Depressive Disorder Drug Revenue in 2021
3.3 Global Major Depressive Disorder Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Major Depressive Disorder Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Major Depressive Disorder Drug Sales by Type
4.1.1 Global Major Depressive Disorder Drug Historical Sales by Type (2017-2022)
4.1.2 Global Major Depressive Disorder Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
4.2 Global Major Depressive Disorder Drug Revenue by Type
4.2.1 Global Major Depressive Disorder Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Major Depressive Disorder Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
4.3 Global Major Depressive Disorder Drug Price by Type
4.3.1 Global Major Depressive Disorder Drug Price by Type (2017-2022)
4.3.2 Global Major Depressive Disorder Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Major Depressive Disorder Drug Sales by Application
5.1.1 Global Major Depressive Disorder Drug Historical Sales by Application (2017-2022)
5.1.2 Global Major Depressive Disorder Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
5.2 Global Major Depressive Disorder Drug Revenue by Application
5.2.1 Global Major Depressive Disorder Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Major Depressive Disorder Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
5.3 Global Major Depressive Disorder Drug Price by Application
5.3.1 Global Major Depressive Disorder Drug Price by Application (2017-2022)
5.3.2 Global Major Depressive Disorder Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Major Depressive Disorder Drug Market Size by Type
6.1.1 North America Major Depressive Disorder Drug Sales by Type (2017-2028)
6.1.2 North America Major Depressive Disorder Drug Revenue by Type (2017-2028)
6.2 North America Major Depressive Disorder Drug Market Size by Application
6.2.1 North America Major Depressive Disorder Drug Sales by Application (2017-2028)
6.2.2 North America Major Depressive Disorder Drug Revenue by Application (2017-2028)
6.3 North America Major Depressive Disorder Drug Market Size by Country
6.3.1 North America Major Depressive Disorder Drug Sales by Country (2017-2028)
6.3.2 North America Major Depressive Disorder Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Major Depressive Disorder Drug Market Size by Type
7.1.1 Europe Major Depressive Disorder Drug Sales by Type (2017-2028)
7.1.2 Europe Major Depressive Disorder Drug Revenue by Type (2017-2028)
7.2 Europe Major Depressive Disorder Drug Market Size by Application
7.2.1 Europe Major Depressive Disorder Drug Sales by Application (2017-2028)
7.2.2 Europe Major Depressive Disorder Drug Revenue by Application (2017-2028)
7.3 Europe Major Depressive Disorder Drug Market Size by Country
7.3.1 Europe Major Depressive Disorder Drug Sales by Country (2017-2028)
7.3.2 Europe Major Depressive Disorder Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Major Depressive Disorder Drug Market Size by Type
8.1.1 Asia Pacific Major Depressive Disorder Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Major Depressive Disorder Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Major Depressive Disorder Drug Market Size by Application
8.2.1 Asia Pacific Major Depressive Disorder Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Major Depressive Disorder Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Major Depressive Disorder Drug Market Size by Region
8.3.1 Asia Pacific Major Depressive Disorder Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Major Depressive Disorder Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Major Depressive Disorder Drug Market Size by Type
9.1.1 Latin America Major Depressive Disorder Drug Sales by Type (2017-2028)
9.1.2 Latin America Major Depressive Disorder Drug Revenue by Type (2017-2028)
9.2 Latin America Major Depressive Disorder Drug Market Size by Application
9.2.1 Latin America Major Depressive Disorder Drug Sales by Application (2017-2028)
9.2.2 Latin America Major Depressive Disorder Drug Revenue by Application (2017-2028)
9.3 Latin America Major Depressive Disorder Drug Market Size by Country
9.3.1 Latin America Major Depressive Disorder Drug Sales by Country (2017-2028)
9.3.2 Latin America Major Depressive Disorder Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Major Depressive Disorder Drug Market Size by Type
10.1.1 Middle East and Africa Major Depressive Disorder Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Major Depressive Disorder Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Major Depressive Disorder Drug Market Size by Application
10.2.1 Middle East and Africa Major Depressive Disorder Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Major Depressive Disorder Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Major Depressive Disorder Drug Market Size by Country
10.3.1 Middle East and Africa Major Depressive Disorder Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Corporation Information
11.1.2 Bristol-Myers Squibb Company Overview
11.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Company Recent Developments
11.2 Cerecor Inc.
11.2.1 Cerecor Inc. Corporation Information
11.2.2 Cerecor Inc. Overview
11.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cerecor Inc. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cerecor Inc. Recent Developments
11.3 e-Therapeutics Plc
11.3.1 e-Therapeutics Plc Corporation Information
11.3.2 e-Therapeutics Plc Overview
11.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 e-Therapeutics Plc Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 e-Therapeutics Plc Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Overview
11.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Corporation Information
11.6.2 GlaxoSmithKline Plc Overview
11.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Plc Recent Developments
11.7 H. Lundbeck A/S
11.7.1 H. Lundbeck A/S Corporation Information
11.7.2 H. Lundbeck A/S Overview
11.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 H. Lundbeck A/S Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 H. Lundbeck A/S Recent Developments
11.8 Hua Medicine Ltd.
11.8.1 Hua Medicine Ltd. Corporation Information
11.8.2 Hua Medicine Ltd. Overview
11.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hua Medicine Ltd. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hua Medicine Ltd. Recent Developments
11.9 Intra-Cellular Therapies, Inc.
11.9.1 Intra-Cellular Therapies, Inc. Corporation Information
11.9.2 Intra-Cellular Therapies, Inc. Overview
11.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Intra-Cellular Therapies, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Major Depressive Disorder Drug Industry Chain Analysis
12.2 Major Depressive Disorder Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Major Depressive Disorder Drug Production Mode & Process
12.4 Major Depressive Disorder Drug Sales and Marketing
12.4.1 Major Depressive Disorder Drug Sales Channels
12.4.2 Major Depressive Disorder Drug Distributors
12.5 Major Depressive Disorder Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Major Depressive Disorder Drug Industry Trends
13.2 Major Depressive Disorder Drug Market Drivers
13.3 Major Depressive Disorder Drug Market Challenges
13.4 Major Depressive Disorder Drug Market Restraints
14 Key Findings in The Global Major Depressive Disorder Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Major Depressive Disorder Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Aripiprazole
Table 3. Major Manufacturers of AV-101
Table 4. Major Manufacturers of AVP-786
Table 5. Major Manufacturers of Basimglurant
Table 6. Major Manufacturers of Brexpiprazole
Table 7. Major Manufacturers of Others
Table 8. Global Major Depressive Disorder Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Major Depressive Disorder Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Major Depressive Disorder Drug Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Major Depressive Disorder Drug Sales Market Share by Region (2017-2022)
Table 12. Global Major Depressive Disorder Drug Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Major Depressive Disorder Drug Sales Market Share by Region (2023-2028)
Table 14. Global Major Depressive Disorder Drug Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Major Depressive Disorder Drug Revenue Market Share by Region (2017-2022)
Table 16. Global Major Depressive Disorder Drug Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Major Depressive Disorder Drug Revenue Market Share by Region (2023-2028)
Table 18. Global Major Depressive Disorder Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Major Depressive Disorder Drug Sales Share by Manufacturers (2017-2022)
Table 20. Global Major Depressive Disorder Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Major Depressive Disorder Drug Revenue Share by Manufacturers (2017-2022)
Table 22. Major Depressive Disorder Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Major Depressive Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Major Depressive Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder Drug as of 2021)
Table 25. Major Depressive Disorder Drug Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Major Depressive Disorder Drug Product Offered
Table 27. Date of Manufacturers Enter into Major Depressive Disorder Drug Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Major Depressive Disorder Drug Sales Share by Type (2017-2022)
Table 32. Global Major Depressive Disorder Drug Sales Share by Type (2023-2028)
Table 33. Global Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Major Depressive Disorder Drug Revenue Share by Type (2017-2022)
Table 36. Global Major Depressive Disorder Drug Revenue Share by Type (2023-2028)
Table 37. Major Depressive Disorder Drug Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Major Depressive Disorder Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Major Depressive Disorder Drug Sales Share by Application (2017-2022)
Table 42. Global Major Depressive Disorder Drug Sales Share by Application (2023-2028)
Table 43. Global Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Major Depressive Disorder Drug Revenue Share by Application (2017-2022)
Table 46. Global Major Depressive Disorder Drug Revenue Share by Application (2023-2028)
Table 47. Major Depressive Disorder Drug Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Major Depressive Disorder Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Major Depressive Disorder Drug Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Major Depressive Disorder Drug Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Major Depressive Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Major Depressive Disorder Drug Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Major Depressive Disorder Drug Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Major Depressive Disorder Drug Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Major Depressive Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Major Depressive Disorder Drug Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Major Depressive Disorder Drug Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Major Depressive Disorder Drug Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Major Depressive Disorder Drug Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Major Depressive Disorder Drug Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Major Depressive Disorder Drug Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Major Depressive Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Major Depressive Disorder Drug Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Major Depressive Disorder Drug Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Major Depressive Disorder Drug Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Major Depressive Disorder Drug Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Major Depressive Disorder Drug Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Major Depressive Disorder Drug Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Major Depressive Disorder Drug Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Major Depressive Disorder Drug Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Major Depressive Disorder Drug Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Major Depressive Disorder Drug Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2023-2028) & (US$ Million)
Table 109. Bristol-Myers Squibb Company Corporation Information
Table 110. Bristol-Myers Squibb Company Description and Major Businesses
Table 111. Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bristol-Myers Squibb Company Recent Developments
Table 114. Cerecor Inc. Corporation Information
Table 115. Cerecor Inc. Description and Major Businesses
Table 116. Cerecor Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Cerecor Inc. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Cerecor Inc. Recent Developments
Table 119. e-Therapeutics Plc Corporation Information
Table 120. e-Therapeutics Plc Description and Major Businesses
Table 121. e-Therapeutics Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. e-Therapeutics Plc Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. e-Therapeutics Plc Recent Developments
Table 124. Eli Lilly and Company Corporation Information
Table 125. Eli Lilly and Company Description and Major Businesses
Table 126. Eli Lilly and Company Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Eli Lilly and Company Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Eli Lilly and Company Recent Developments
Table 129. F. Hoffmann-La Roche Ltd. Corporation Information
Table 130. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 131. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. F. Hoffmann-La Roche Ltd. Recent Developments
Table 134. GlaxoSmithKline Plc Corporation Information
Table 135. GlaxoSmithKline Plc Description and Major Businesses
Table 136. GlaxoSmithKline Plc Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. GlaxoSmithKline Plc Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. GlaxoSmithKline Plc Recent Developments
Table 139. H. Lundbeck A/S Corporation Information
Table 140. H. Lundbeck A/S Description and Major Businesses
Table 141. H. Lundbeck A/S Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. H. Lundbeck A/S Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. H. Lundbeck A/S Recent Developments
Table 144. Hua Medicine Ltd. Corporation Information
Table 145. Hua Medicine Ltd. Description and Major Businesses
Table 146. Hua Medicine Ltd. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Hua Medicine Ltd. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Hua Medicine Ltd. Recent Developments
Table 149. Intra-Cellular Therapies, Inc. Corporation Information
Table 150. Intra-Cellular Therapies, Inc. Description and Major Businesses
Table 151. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 152. Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Intra-Cellular Therapies, Inc. Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Major Depressive Disorder Drug Distributors List
Table 157. Major Depressive Disorder Drug Customers List
Table 158. Major Depressive Disorder Drug Market Trends
Table 159. Major Depressive Disorder Drug Market Drivers
Table 160. Major Depressive Disorder Drug Market Challenges
Table 161. Major Depressive Disorder Drug Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Major Depressive Disorder Drug Product Picture
Figure 3. Global Major Depressive Disorder Drug Market Share by Type in 2021 & 2028
Figure 3. Aripiprazole Product Picture
Figure 4. AV-101 Product Picture
Figure 5. AVP-786 Product Picture
Figure 6. Basimglurant Product Picture
Figure 7. Brexpiprazole Product Picture
Figure 8. Others Product Picture
Figure 9. Global Major Depressive Disorder Drug Market Share by Application in 2021 & 2028
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Research Center
Figure 13. Major Depressive Disorder Drug Report Years Considered
Figure 14. Global Major Depressive Disorder Drug Sales 2017-2028 (K Pcs)
Figure 15. Global Major Depressive Disorder Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Major Depressive Disorder Drug Revenue 2017-2028 (US$ Million)
Figure 17. Global Major Depressive Disorder Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Major Depressive Disorder Drug Sales Market Share by Region (2017-2022)
Figure 19. Global Major Depressive Disorder Drug Sales Market Share by Region (2023-2028)
Figure 20. North America Major Depressive Disorder Drug Sales YoY (2017-2028) & (K Pcs)
Figure 21. North America Major Depressive Disorder Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Major Depressive Disorder Drug Sales YoY (2017-2028) & (K Pcs)
Figure 23. Europe Major Depressive Disorder Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Major Depressive Disorder Drug Sales YoY (2017-2028) & (K Pcs)
Figure 25. Asia-Pacific Major Depressive Disorder Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Major Depressive Disorder Drug Sales YoY (2017-2028) & (K Pcs)
Figure 27. Latin America Major Depressive Disorder Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Major Depressive Disorder Drug Sales YoY (2017-2028) & (K Pcs)
Figure 29. Middle East & Africa Major Depressive Disorder Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Major Depressive Disorder Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Major Depressive Disorder Drug in the World: Market Share by Major Depressive Disorder Drug Revenue in 2021
Figure 32. Global Major Depressive Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 37. North America Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 39. North America Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 41. North America Major Depressive Disorder Drug Sales Share by Country (2017-2028)
Figure 42. North America Major Depressive Disorder Drug Revenue Share by Country (2017-2028)
Figure 43. U.S. Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 47. Europe Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 49. Europe Major Depressive Disorder Drug Sales Share by Country (2017-2028)
Figure 50. Europe Major Depressive Disorder Drug Revenue Share by Country (2017-2028)
Figure 51. Germany Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 52. France Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Major Depressive Disorder Drug Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Major Depressive Disorder Drug Revenue Share by Region (2017-2028)
Figure 62. China Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 65. India Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 73. Latin America Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 75. Latin America Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Major Depressive Disorder Drug Sales Share by Country (2017-2028)
Figure 77. Latin America Major Depressive Disorder Drug Revenue Share by Country (2017-2028)
Figure 78. Mexico Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Major Depressive Disorder Drug Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Major Depressive Disorder Drug Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Major Depressive Disorder Drug Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Major Depressive Disorder Drug Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Major Depressive Disorder Drug Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Major Depressive Disorder Drug Revenue Share by Country (2017-2028)
Figure 87. Turkey Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Major Depressive Disorder Drug Revenue (2017-2028) & (US$ Million)
Figure 90. Major Depressive Disorder Drug Value Chain
Figure 91. Major Depressive Disorder Drug Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed